LAUSR

nstitute of Pathology,MedicalUniversity ofGraz,Graz, Austria; enter for Biomarker Research in Medicine, Graz, Austria; epartment of Medical Oncology, Dana-Farber Cancer Instite, 450 Brookline Avenue, Boston, MA 02215, USA; epartment of Pharmacy, Pharmaceutical Biology, Saarland niversity, Saarbrücken, Germany; Liver Tumor Translational esearch Program, University of Texas Southwestern Medical enter, Dallas, USA; Center for Cancer Research, assachusetts General Hospital, Harvard Medical School, oston, USA; Institute for Medical Informatics, Statistics and ocumentation, Medical University of Graz, Graz, Austria; Institute of Medical Engineering, Graz University of chnology, Graz, Austria; Institute of Molecular Biosciences, niversity of Graz, Graz, Austria; AG VABOS, Department of ranio-Maxillofacial Surgery, Univerity of Muenster, Germany; Clinical Institute of Medical and Chemical Laboratory iagnostics, Medical University of Graz, Graz, Austria; Department of Chemistry, Linköping University, Linköping, eden; Biomodels Austria (Biat), University of Veterinary edicine Vienna, Vienna, Austria; Department IFA-Tulln, niversity for Natural Resources and Applied Life Sciences enna, Vienna, Austria; Institute of Laboratory Animal ience, University of Veterinary Medicine Vienna, Vienna, ustria; Institute of Biology, University of Leipzig, Leipzig, ermany; Department of Internal Medicine III, University ospital RWTH Aachen, Aachen, Germany; Institute of nimal Breeding and Genetics, University of Veterinary edicine Vienna, Vienna, Austria; Ludwig Bolzmann stitute of Cancer Research, Vienna, Austria; Medical niversity Vienna, Vienna, Austria; Department of thology, Medical Faculty, Otto-von-Guericke-University Magburg, Magdeburg, Germany